Sharon E Murphy Selected Research

Sharon E Murphy Research Topics

Disease

25	Lung Neoplasms (Lung Cancer) 01/2021 - 12/2003
11	Neoplasms (Cancer) 10/2020 - 02/2003
5	Tobacco Use Disorder (Nicotine Dependence) 11/2021 - 11/2008
4	Inflammation (Inflammations) 01/2020 - 07/2016
4	Carcinogenesis 03/2016 - 02/2003
3	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2022 - 01/2011
1	Asthma (Bronchial Asthma) 01/2022
1	Mental Disorders (Mental Disorder) 12/2019
1	Psychotic Disorders (Schizoaffective Disorder) 12/2019
1	Schizophrenia (Dementia Praecox) 12/2019
1	Bipolar Disorder (Manic Depressive Psychosis) 12/2019
1	Wounds and Injuries (Trauma) 11/2013
1	Trimethylaminuria 02/2013
1	Adenoma (Adenomas) 11/2011
1	Carcinoma (Carcinomatosis) 11/2011
1	Heart Diseases (Heart Disease) 03/2008
1	Lung Diseases (Lung Disease) 12/2005
1	Esophageal Neoplasms (Esophageal Cancer) 02/2003

Drug/Important Bio-Agent (IBA)

27	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2005
19	Nicotine FDA Link 01/2022 - 03/2008
15	CarcinogensIBA 10/2020 - 02/2003
11	SmokeIBA 10/2020 - 12/2003
10	CotinineIBA 01/2020 - 03/2008
5	4- (methylnitrosamino)- 1- (3- pyridyl)- 1- butan- 1- olIBA 12/2019 - 03/2008
5	4- (N- methyl- N- nitrosamino)- 1- (3- pyridyl)- 1- butanoneIBA 03/2016 - 05/2006
4	NitrosaminesIBA 04/2009 - 02/2003
3	Dinoprostone (PGE2)FDA Link 01/2019 - 07/2016
2	DNA AdductsIBA 10/2020 - 03/2016
2	ORALIT (ORS)IBA 01/2020 - 11/2011
2	7- hydroxy- 5,11- dioxotetranorprostane- 1,16- dioic acidIBA 01/2019 - 01/2019
2	EicosanoidsIBA 01/2019 - 01/2019
2	AcidsIBA 01/2019 - 01/2019
2	F2-Isoprostanes (F2 Isoprostanes)IBA 01/2019 - 03/2008
2	hydroxycotinineIBA 01/2017 - 03/2016
2	EnzymesIBA 01/2017 - 07/2011
2	phenethyl isothiocyanate (PEITC)IBA 07/2016 - 01/2016
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 05/2016 - 07/2011
2	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 02/2014 - 11/2011
2	dimethylaniline monooxygenase (N-oxide forming) (flavin-containing monooxygenase)IBA 02/2013 - 07/2011
2	GlucuronidesIBA 11/2011 - 03/2008
2	N-NitrosopyrrolidineIBA 01/2005 - 02/2003
2	4-nitrophenyl myo-inositol-1-phosphateIBA 10/2003 - 02/2003
1	Biological ProductsIBA 01/2020
1	Dihydrotachysterol (AT 10)IBA 01/2019
1	CreatinineIBA 01/2017
1	IsothiocyanatesIBA 07/2016
1	7,8-dihydromethysticinIBA 03/2016
1	1,3-butadiene (divinyl)IBA 11/2014
1	hydroxide ionIBA 02/2014
1	Volatile Organic CompoundsIBA 02/2014
1	N'-nitrosonornicotine (nitrosonornicotine)IBA 06/2013
1	trimethylamineIBA 02/2013
1	r- 1,t- 2,3,c- 4- tetrahydroxy- 1,2,3,4- tetrahydrophenanthreneIBA 11/2011
1	Uridine Diphosphate (UDP)IBA 07/2011
1	TransferasesIBA 07/2011
1	4,6-dinitro-o-cresol (DNOC)IBA 07/2011
1	Mixed Function Oxygenases (Monooxygenases)IBA 07/2011
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 11/2008
1	1-hydroxypyreneIBA 03/2008
1	Fibrinogen (Factor I)FDA Link 03/2008
1	C-Reactive ProteinIBA 03/2008
1	Carbon MonoxideIBA 03/2008
1	nitrosamine 4- (methylnitrosamino)- 1- (3- pyridyl)- 1- butanoneIBA 12/2003
1	N-nitrosopiperidineIBA 02/2003

Therapy/Procedure

2	Chemoprevention 10/2020 - 02/2008
1	Tobacco Use Cessation Devices 02/2010